The Food and Drug Administration approved the first injectable treatment for use by HIV-negative people to prevent infection, allowing people to ditch a daily pill in exchange for a shot every two months.

“Today’s approval adds an important tool in the effort to end the HIV epidemic by providing the first option to prevent HIV that does not involve taking a daily pill,” said Dr. Debra Birnkrant, the director of the Division of Antivirals in the FDA’s Center for Drug Evaluation and Research.